References
- Dollar JR, Blackwell RE. Diagnosis and management of prolactinomas. Cancer Metastasis Rev. 1986;5(2):125–138. doi:https://doi.org/10.1007/BF00046427.
- Colao A. Pituitary tumours: the prolactinoma. Best Pract Res Clin Endocrinol Metab. 2009;23(5):575–596. doi:https://doi.org/10.1016/j.beem.2009.05.003.
- Vicchi FL, Luque GM, Brie B, et al. Dopaminergic drugs in type 2 diabetes and glucose homeostasis. Pharmacol Res. 2016;109:74–80. doi:https://doi.org/10.1016/j.phrs.2015.12.029.
- Erdem S, Karahan M, Ava S, Pekkolay Z, Demirtas AA, Keklikci U. The effectiveness of automatic pupillometry as a screening method to detect diabetic autonomic neuropathy. Int Ophthalmol. 2020;40(11):3127–3134. doi:https://doi.org/10.1007/s10792-020-01499-x.
- Fotiou F, Goulas A, Fountoulakis K, et al. Changes in psychophysiological processing of vision in myasthenia gravis. Int J Psychophysiol. 1998;29(3):303–310. doi:https://doi.org/10.1016/S0167-8760(98)00005-1.
- Gordan R, Gwathmey JK, Xie LH. Autonomic and endocrine control of cardiovascular function. World J Cardiol. 2015;7(4):204–214. doi:https://doi.org/10.4330/wjc.v7.i4.204.
- Shannon RP, Mead A, Sears ML. The efect of dopamine on the intraocular pressure and pupil of the rabbit eye. Invest Ophthalmol. 1976;15:371–380.
- Tekin K, Sekeroglu MA, Kiziltoprak H, et al. Static and dynamic pupillometry data of healthy individuals. Clin Exp Optometry. 2018;101(5):659–665. doi:https://doi.org/10.1111/cxo.12659.
- Erdem S, Yilmaz S, Karahan M, et al. Can dynamic and static pupillary responses be used as an indicator of autonomic dysfunction in patients with obstructive sleep apnea syndrome? Int Ophthalmol. 2021:1–9. doi:https://doi.org/10.1007/s10792-020-01545-8.
- Prettyman R, Bitsios P, Szabadi E. Altered pupillary size and darkness and light reflexes in Alzheimer’s disease. J Neurol Neurosurg Psychiatry. 1997;62:665–668. doi:https://doi.org/10.1136/jnnp.62.6.665.
- Lüdtke H, Kriegbaum C, Leo-Kottler B, et al. H. Pupillary light reflexes in patients with Leber’s hereditary optic neuropathy. Graefes Arch Clin Exp Ophthalmol. 1999;237(3):207–211. doi:https://doi.org/10.1007/s004170050220.
- Van Diemen HA, Van Dongen MM, Natura JJ, et al. Pupillary light reflex latency in patients with multiple sclerosis. Electroencephalogr Clin Neurophysiol. 1992;82:213–219. doi:https://doi.org/10.1016/0013-4694(92)90170-M.
- Bitsios P, Szabadi E, Bradshaw CM. Comparison of the effects of venlafaxine, paroxetine and desipramine on the pupillary light reflex in man. Psychopharmacology (Berl). 1999;143(3):286–292. doi:https://doi.org/10.1007/s002130050949.
- Besada E, Reed K, Najman P, Shechtman D, Hardigan P. Pupillometry study of brimonidine tartrate 0.2% and apraclonidine 0.5%. J Clin Pharmacol. 2011;51(12):1690–1695. doi:https://doi.org/10.1177/0091270010385932.
- Bartošová O, Bonnet C, Ulmanová O, et al. Pupillometry as an indicator of l-DOPA dosages in Parkinson’s disease patients. J Neural Transm. 2018;125(4):699–703. doi:https://doi.org/10.1007/s00702-017-1829-1.
- Fotiou F, Fountoulakis KN, Goulas A, et al. Automated standardized pupillometry with optical method for purposes of clinical practice and research. Clin Physiol. 2000;20(5):336–347. doi:https://doi.org/10.1046/j.1365-2281.2000.00259.x.
- Bremner F. Pupil evaluation as a test for autonomic disorders. Clin Auton Res. 2009;19(2):88–101. doi:https://doi.org/10.1007/s10286-009-0515-2.
- Jaradeh SS, Prieto TE. Evaluation of the autonomic nervous system. Phys Med Rehabil Clin. 2003;14(2):287–305. doi:https://doi.org/10.1016/s1047-9651(02)00121-3.
- Crosignani PG. Current treatment issues in female hyperprolactinaemia. Eur J Obstet Gynecol Reprod Biol. 2006;125(2):152–164. doi:https://doi.org/10.1016/j.ejogrb.2005.10.005.
- Schoors DF, Vauquelin GP, De Vos H, et al. Identification of a D1 dopamine receptor, not linked to adenylate cyclase, on lactotroph cells. Br J Pharmacol. 1991;103(4):1928–1934. doi:https://doi.org/10.1111/j.1476-5381.1991.tb12354.x.
- Mannelli M, Lazzeri C, Ianni L, et al. Dopamine and sympathoadrenal activity in man. Clin Exp Hyperten. 1997;19(1–2):163–179. doi:https://doi.org/10.3109/10641969709080813.
- Ben-Jonathan N, Hnasko R. Dopamine as a prolactin (PRL) inhibitor. Endocr Rev. 2001;22:724–763. doi:https://doi.org/10.1210/edrv.22.6.0451.
- Korczyn AD, Keren O. The effect of dopamine on the pupillary diameter in mice. Life Sci. 1980;26(10):757–763. doi:https://doi.org/10.1016/0024-3205(80)90280-5.
- Wensing G, Haase C, Brendel E, et al. Pupillography as a sensitive, noninvasive biomarker in healthy volunteers: first-in-man study of BAY 63–9044, a new 5-HT 1A-receptor agonist with dopamine agonistic properties. Eur J Clin Pharmacol. 2007;63(12):1123–1128. doi:https://doi.org/10.1007/s00228-007-0372-7.
- Samuels ER, Hou RH, Langley RW, et al. Comparison of pramipexole and modafinil on arousal, autonomic, and endocrine functions in healthy volunteers. J Psychopharmacol. 2006;20(6):756–770. doi:https://doi.org/10.1177/0269881106060770.